[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100571067":3},{"organization":4,"outcomesModule":7,"designInfo":22,"detailedDescription":24,"studyPopulation":25,"armGroups":26,"interventions":11,"overallOfficials":11,"centralContacts":30,"locations":36,"responsibleParty":53,"collaborators":55,"id":72,"slug":73,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":76,"acronym":77,"eligibilityCriteria":78,"healthyVolunteers":74,"sex":79,"minAge":80,"maxAge":81,"enrollmentInfo":82,"targetDuration":85,"studyType":86,"phases":11,"briefSummary":87,"conditions":88,"keywords":91,"overallStatus":96,"whyStopped":11,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":101,"completionDateStruct":103,"leadSponsor":105,"locationsCount":106},{"fullName":5,"class":6},"Epicentre","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":11,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"Recovery with SPO2 above 92%",null,"From enrollment to day 3 to 10",[14,18],{"measure":15,"description":16,"timeFrame":17},"Acceptability, feasibility and perception from the caretaker point of view","interview of the caretaker","2 weeks after hospitalisation",{"measure":19,"description":20,"timeFrame":21},"Acceptability, feasibility and perception from the health staff point of view","Interview of the health staffs (doctors, nurses, biomed, managers, logisticians)","From Month 2 until Month 12",{"allocation":11,"interventionModel":11,"interventionModelDescription":11,"primaryPurpose":11,"observationalModel":6,"timePerspective":23,"maskingInfo":11},"PROSPECTIVE","Mixed method study: quantitative component for the data of the children and qualitative data for the perception for health staffs and parents","MSF pediatric ICU in 4 sites (Herat- Afghanistan, Kenema- Sierra Leone, Goyalmara hospital for Rohingya refugee - Bangladesh, Khamir- Yemen)",[27],{"label":28,"type":11,"description":29,"interventionNames":11},"Pediactric ICU Hospitalized children 1mo to 5 yo","Prescription of HFNO therapy",[31],{"name":32,"role":33,"phone":34,"phoneExt":11,"email":35},"Elisabeth Poulet, MD, Msc","CONTACT","0033140215465","elisabeth.poulet@epicentre.msf.org",[37],{"facility":38,"status":11,"city":39,"state":11,"zip":11,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Herat regional Hospital","Herat","Afghanistan","AF",{"type":43,"coordinates":44},"Point",[45,46],62.19967,34.34817,{"lat":46,"lon":45},[49],{"name":50,"role":33,"phone":51,"phoneExt":11,"email":52},"Hamayoun Hemat, MD","0093782174114","Msf-afghanistan-medcopdep@msf.org",{"type":54,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[56,59,61,63,65,67,69],{"name":57,"class":58},"MOH Afghanistan","UNKNOWN",{"name":60,"class":58},"MOH Bangladesh",{"name":62,"class":58},"MOH Sierra Leone",{"name":64,"class":58},"MOH Yemen",{"name":66,"class":58},"MSF Médecins Sans Frontières Belgium",{"name":68,"class":58},"MSF Médecins Sans Frontières France",{"name":70,"class":71},"Fisher and Paykel Healthcare","INDUSTRY","100571067","high-flow-nasal-oxygen-therapy-an-implementation-study-in-pediatric-wards-100571067",false,"NCT06715423","High Flow Nasal Oxygen Therapy an Implementation Study in Pediatric Wards","HFNO","Inclusion Criteria:\n\n* prescription of HFNO by clinician\n* parent consenting to the use of the data","ALL","1 Month","5 Years",{"count":83,"type":84},960,"ESTIMATED","2 Weeks","OBSERVATIONAL","The purpose of this study is to prospectively evaluate the process of implementing HFNO in several MSF projects, varying according to geographical and programmatic contexts, population, health structures, human resources, and management. It will generate evidence on the operational feasibility (in terms of human resources, equipment, logistics and costs) of integrating HFNO into PICU standard of care, as well as on the users' and caregivers' perspectives on HFNO and on the children clinical outcomes observed where HFNO is implemented. This relevant information will guide MSF in the decision making of scaling up HFNO therapy in its projects.",[89,90],"Moderate Respiratory Distress","Severe Respiratory Distress",[92,93,94,95],"oxygen","high flow","pneumonia","pediatrics","NOT_YET_RECRUITING","2025-01-28",{"date":99,"type":100},"2025-01-30","ACTUAL",{"date":102,"type":84},"2025-01",{"date":104,"type":84},"2025-12",{"name":5,"class":6},1]